Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Comparison of Metronidazole-based Triple and Bismuth-based Quadruple Therapy for Clarithromycin Resistant-Helicobacter Pylori Infection: Randomized Controlled Trial

NCT03431688 is registered in ClinicalTrials.gov with Kangdong Sacred Heart Hospital as lead sponsor.

NCT NCT03431688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03431688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Comparison of Metronidazole-based Triple and Bismuth-based Quadruple Therapy for Clarithromycin Resistant-Helicobacter Pylori Infection: Randomized Controlled Trial
Lead sponsor
Kangdong Sacred Heart Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2018
Completion date
December 30, 2020
Enrollment
782 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection